ArticleCancer drug resistance (Alhambra, Calif.)2025

FGFR1 overexpression promotes resistance to PI3K inhibitor alpelisib in luminal breast cancer cells through receptor tyrosine kinase signaling-mediated activation of the estrogen receptor.

Yujie Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.